CA-MATRIXX-SOFTWARE
11.6.2019 10:02:11 CEST | Business Wire | Press release
MATRIXX Software , an innovation powerhouse committed to transforming global commerce, today announced that Roshan, Afghanistan’s leading telecommunications service provider, has selected MATRIXX Digital Commerce to transform their operations and grow revenue.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190611005211/en/
Roshan is partnering with MATRIXX Software to change the way its six million customers use telecom services by bringing real-time digital experience and personalization for all voice, data and digital services.
MATRIXX has a global customer footprint across Europe, the Middle East, Asia and North America. Roshan selected MATRIXX because it is the only vendor providing a single platform that both protects and grows revenues from traditional prepaid voice and messaging services while also delivering the tools to attract smartphone users and increase data usage. As the digital revolution sweeps through emerging markets, mobile operators need cost effective, scalable solutions that improve their existing operating portfolios while building for the future of smartphones and digital service revenues.
In a signing ceremony in Dubai, UAE, Roshan’s CEO Karim Khoja said, “Since our founding, Roshan has always embraced implementing new technologies and applications to provide our customers with the best experience. This partnership with MATRIXX Software showcases that the digital experience is quickly becoming a reality in Afghanistan.”
“Afghanistan’s communications infrastructure has come a long way in 16 years and Roshan has played and continues to play a significant role in making that happen,” said Dave Labuda, MATRIXX Software co-founder and CEO. “It is only natural that Roshan is leading the way into a new era of digital connectivity. We are proud to be a part of helping Roshan deliver the future of customer experience and service innovation that Roshan aims to bring to their customers.”
Built entirely from scratch, the multi-patented, award-winning MATRIXX Digital Commerce Platform enables a digital-first reinvention of Telco BSS. It brings together traditionally separate network and IT functions into a single platform including product design and lifecycle management, customer engagement, service delivery and monetization. Built for digital, the MATRIXX Digital Commerce Platform offers operators the agility and seamless scalability required to compete and win now and in the future.
Roshan has always been a pioneer in leveraging its robust network infrastructure and technology to support the government and the people of Afghanistan. These include the launch of Afghanistan’s first ever mobile money service, M-Paisa, which has contributed to increasing financial transparency and financial inclusion. Roshan also launched the first Telemedicine program in Afghanistan in 2007, linking hospitals in Badakhshan, Bamiyan and Kandahar provinces to the French Medical Institute for Children and Mothers (FMIC) in Kabul, one of the most modern hospitals in the country. Since its launch, almost 30,000 patients across Afghanistan have received treatment through this telemedicine link.
About Roshan
Roshan (Telecom Development Company Afghanistan Ltd) is Afghanistan's leading total communications provider with 6 million active subscribers and a network that covers over 287 districts and cities in all of the country's 34 provinces.
Roshan is a true Afghanistan success story, serving as a catalyst for economic growth and actively contributing to the country’s long-term development. Since its inception in 2003, Roshan has invested approximately $750 million in Afghanistan and is the country’s single largest private investor and taxpayer, contributing approximately five percent of the Afghan government's overall domestic revenue. Roshan directly employs around 900 people, 20 percent of whom are women, and provides indirect employment to more than 35,000 people. Roshan is deeply committed to Afghanistan’s reconstruction and development.
The Aga Khan Fund for Economic Development (AKFED), part of the Aga Khan Development Network (AKDN), is a major shareholder of Roshan and promotes private initiatives and building economically sound enterprises in the developing world. Also owned in part by Monaco Telecom International (MTI) and Telia, Roshan brings international expertise to the country and is committed to the highest standards of network quality and coverage for the people of Afghanistan.
To learn more about Roshan visit www.roshan.af or http://www.facebook.com/RoshanConnects . You can also follow us on Twitter @roshanconnects .
About MATRIXX Software
MATRIXX Software provides next-generation, cloud native digital commerce solutions that transform how companies do business. Serving many of the world’s largest communications companies, IoT players and emerging digital service providers, MATRIXX is committed to delivering a modern commerce platform that easily scales to support global market places and consumption-based services. Through its relentless commitment to product excellence and customer success, MATRIXX empowers businesses to reinvent themselves and succeed as a digital leader.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190611005211/en/
Contact:
Mercury Global Partners for MATRIXX Software Natalee Gibson, Managing Director matrixx@mercuryglobalpartners.com +1 720 648 5784
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom